Ronnie Hershmann
Director/Board Member at HEMOSTEMIX INC.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Thomas Smeenk | M | - | 18 years | |
Dalia Megiddo | M | 72 |
Nasus Pharma Ltd.
Nasus Pharma Ltd. Medical SpecialtiesHealth Technology Nasus Pharma Ltd. is a pharmaceutical company based in Tel Aviv, Israel. The Israeli company specializes in developing intranasal powder products to assist patients in acute emergency situations such as opioid overdose and anaphylactic shock. The private company's portfolio includes intranasal naloxone and intranasal epinephrine, as well as several preclinical programs. Nasus Pharma's unique patented technology creates a unique combination of two homogenous particle populations. The company has presented clinical results at various conferences and are dedicated to addressing acute medical conditions and public health threats. The company was founded by Udi Gilboa and Dalia Megiddo. | - |
Peter Lacey | M | 67 | 4 years | |
Galina Temstin Krayz | M | - |
SoluBest Ltd.
SoluBest Ltd. Pharmaceuticals: MajorHealth Technology SoluBest Ltd. develops proprietary nano-transport drug systems. Its products include fenofibrate, albendazole, resveratrol and testosterone undecanoate. The company was founded in 2001 and is headquartered in Ness Ziona, Isreal. | - |
Udi Gilboa | M | 57 |
Nasus Pharma Ltd.
Nasus Pharma Ltd. Medical SpecialtiesHealth Technology Nasus Pharma Ltd. is a pharmaceutical company based in Tel Aviv, Israel. The Israeli company specializes in developing intranasal powder products to assist patients in acute emergency situations such as opioid overdose and anaphylactic shock. The private company's portfolio includes intranasal naloxone and intranasal epinephrine, as well as several preclinical programs. Nasus Pharma's unique patented technology creates a unique combination of two homogenous particle populations. The company has presented clinical results at various conferences and are dedicated to addressing acute medical conditions and public health threats. The company was founded by Udi Gilboa and Dalia Megiddo. | - |
Sabina Glozman | M | - |
SoluBest Ltd.
SoluBest Ltd. Pharmaceuticals: MajorHealth Technology SoluBest Ltd. develops proprietary nano-transport drug systems. Its products include fenofibrate, albendazole, resveratrol and testosterone undecanoate. The company was founded in 2001 and is headquartered in Ness Ziona, Isreal. | - |
Loran Swanberg | M | - | 4 years | |
Bruce S. Morra | M | 70 |
SoluBest Ltd.
SoluBest Ltd. Pharmaceuticals: MajorHealth Technology SoluBest Ltd. develops proprietary nano-transport drug systems. Its products include fenofibrate, albendazole, resveratrol and testosterone undecanoate. The company was founded in 2001 and is headquartered in Ness Ziona, Isreal. | - |
Rodney Kasan | M | - |
SoluBest Ltd.
SoluBest Ltd. Pharmaceuticals: MajorHealth Technology SoluBest Ltd. develops proprietary nano-transport drug systems. Its products include fenofibrate, albendazole, resveratrol and testosterone undecanoate. The company was founded in 2001 and is headquartered in Ness Ziona, Isreal. | - |
Marcus Cohn | M | - |
SoluBest Ltd.
SoluBest Ltd. Pharmaceuticals: MajorHealth Technology SoluBest Ltd. develops proprietary nano-transport drug systems. Its products include fenofibrate, albendazole, resveratrol and testosterone undecanoate. The company was founded in 2001 and is headquartered in Ness Ziona, Isreal. | - |
Fraser Henderson | M | - | 3 years | |
Christina Wu | F | - | 4 years | |
Dov Amar | M | - |
Nasus Pharma Ltd.
Nasus Pharma Ltd. Medical SpecialtiesHealth Technology Nasus Pharma Ltd. is a pharmaceutical company based in Tel Aviv, Israel. The Israeli company specializes in developing intranasal powder products to assist patients in acute emergency situations such as opioid overdose and anaphylactic shock. The private company's portfolio includes intranasal naloxone and intranasal epinephrine, as well as several preclinical programs. Nasus Pharma's unique patented technology creates a unique combination of two homogenous particle populations. The company has presented clinical results at various conferences and are dedicated to addressing acute medical conditions and public health threats. The company was founded by Udi Gilboa and Dalia Megiddo. | - |
Peter Pavlin | M | - | 2 years | |
Cameron Cole | M | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Bryson Goodwin | M | - | 1 years | |
Yari Nieken | M | - | 1 years | |
Kentaro Hosomi | M | 66 | - | |
Bob Deresiewicz | M | - |
Icahn School of Medicine at Mount Sinai
| 3 years |
Steven Mento | M | 72 |
Icahn School of Medicine at Mount Sinai
| 2 years |
Andrew H. Dombro | M | - |
Icahn School of Medicine at Mount Sinai
| 4 years |
Steven Galson | M | 67 |
Icahn School of Medicine at Mount Sinai
| 3 years |
Rich Johnson | M | - |
Icahn School of Medicine at Mount Sinai
| 4 years |
Orin Levy | M | - |
Icahn School of Medicine at Mount Sinai
| 4 years |
Steven A. Kaplan | M | 66 |
Icahn School of Medicine at Mount Sinai
| 3 years |
Pierre Leimgruber | M | - | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
Canada | 11 | 42.31% |
Israel | 8 | 30.77% |
United States | 7 | 26.92% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ronnie Hershmann
- Personal Network